Welcome to the e-CCO Library!

P755: Impaired antibody seroconversion after COVID-19 vaccination and negative impact of immunosuppressive treatment in Inflammatory Bowel Disease. Results from a multicentre, prospective study of GETECCU (VACOVEII).
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Julián, A.B.(1)*;Casas-Deza, D.(1);Vicente-Lidón, R.(1);Beltrán, B.(2);Domènech, E.(3);Gutiérrez-Casbas, A.(4,5);Mañosa, M.(3);Zabana, Y.(5,6);Caudevilla-Biota, E.(7);Corsino-Roche, P.(1,7);Sierra-Moros, E.(1);Franco-Fobe, L.E.(8);Pina-Echevarría, S.(8);García-González, E.(9);Alfambra, E.(7,10);Gargallo-Pueyo, C.(7,10);Sicilia, B.(11);Arias, L.(11);Alcala-Escriche, M.J.(12);Madero-Velázquez, L.(4);Ferreiro-Iglesias, R.(13);Palmero-Pérez, A.(14);Calafat, M.(3,5);Rubio-Iturria, S.(15);Moraleja-Yudego, I.(16);Ber-Nieto, Y.(17);García-Mateo, S.(10);P. Gisbert, J.(5,18,19);Barreiro-de Acosta, M.(13);García-López, S.(1,7);
Created: Friday, 14 July 2023, 11:12 AM
P755: Inflammatory bowel disease and risk of Type 2 diabetes: a nationwide Danish cohort study 1977–2014
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Jess1, B. Wang Jensen1, M. Andersson2, M. Villumsen*1, K. Højgaard Allin1

Created: Friday, 22 February 2019, 9:41 AM
P755: NUDT15 polymorphism is associated with thiopurine-related leukopenia independently of 6-thioguanine nucleotide levels in Korean paediatric inflammatory bowel disease patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kang B.*1, Choi J.Y.1, Lee K.1, Lee S.-Y.2, Ahn S.H.3, Lee H.J.4, Choe Y.H.1

Created: Wednesday, 20 February 2019, 10:36 AM
P755: Safety, efficacy, and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-TNF
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Ben-Horin1*, B. Ungar1, U. Kopylov1, A. Lahat1, M. Yavzori1, E. Fudim1, O. Picard1, Y. Peled2, R. Eliakim1, E. Del Tedesco3, S. Paul4, X. Roblin4

Created: Thursday, 21 February 2019, 9:14 AM
P756 Cervical smear screening results amongst women with inflammatory bowel disease at an Irish hospital
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Pillay, R.S. Piggott, N. Ganter, G. McCormack

Created: Thursday, 30 January 2020, 10:12 AM
P756: Assessment of metal exposures in deciduous teeth of patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Nair*1, C. Austin2, M. Rocha3, C. Gouveia3, P. Curtin2, C. Eisele1, J-f. Colombel4, J. Torres3,4, I. Peter1, M. Arora2

Created: Friday, 22 February 2019, 9:41 AM
P756: Comorbidities in adolescents with inflammatory bowel disease: Findings from a population-based cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

I. Ghersin1*, L.H. Katz2, S. Daher3, R. Shamir4, A. Assa4

Created: Thursday, 21 February 2019, 9:14 AM
P756: Cumulative adverse events of anti-TNF therapy in IBD patients at a large tertiary centre – a 13-year real-world experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Majumder, S.(1,2,3);Love, M.(3);Davis, J.(3);Sharma, N.(4);Nabil Quraishi, M.(3);Cooney, R.(3);Ghosh, S.(5);Iacucci, M.(1,3,6);N Shivaji, U.(1,3,6)*;
Created: Friday, 14 July 2023, 11:12 AM
P756: Diagnosing rare inherited disorders using targeted next generation sequencing in patients with early-onset inflammatory bowel disease: a population-based study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Broly F.*1,2,3, Fumery M.4, Vasseur F.5, Savoye G.6, Ley D.7, Sarter H.8, Dupas J.-L.9, Turck D.7, Gower-Rousseau C.10

Created: Wednesday, 20 February 2019, 10:36 AM
P757 Focusing on the future: Reducing barriers and improving access to inflammatory bowel disease specialty care across Canada
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C.G. Heisler1, R. Mirza2, O. Kits3, S. Zelinsky4, S. Veldhuyzen van Zanten5, G. Nguyen6, J. McCurdy7, M. MacMillan8, P.L. Lakatos9, L. Targownik6, S. Fowler10, K. Rioux11, J. Jones12

Created: Thursday, 30 January 2020, 10:12 AM
P757: Genotype-serotype interactions shed light on of the pathophysiology inflammatory bowel diseases
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ben-Shachar S.*1,2, Finezilber Y.3, Elad H.3, Yanai H.2,3, Dotan I.2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P757: Long-term effectiveness and safety of adalimumab based on Crohn’s disease duration: Results from the PYRAMID registry
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.V. Loftus Jr.1*, W. Reinisch2, R. Panaccione3, S. Berg4, M. Bereswill5, J. Kalabic5, M. Skup6, J. Petersson6, A.M. Robinson6, G. D'Haens7

Created: Thursday, 21 February 2019, 9:14 AM
P757: Prevalence of inflammatory bowel disease (IBD) in a colorectal cancer population screening program
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Bezzio*1, I. Arena1, C. Della Corte1, M. Devani1, G. Manes1, B. Omazzi1, S. Saibeni1

Created: Friday, 22 February 2019, 9:41 AM
P757: Visceral adiposity and not subcutaneous adiposity or body mass index is more strongly associated with relapse in inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tan, J.(1)*;Shadbolt, B.(2);Jain, T.(3);Subramaniam, K.(1);
Created: Friday, 14 July 2023, 11:12 AM
P758 Ileorectal anastomosis vs. ileal pouch-anal anastomosis for the surgical treatment of ulcerative colitis: A Markov decision analysis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. De Buck Van Overstraeten1,2,3, M. Brar1,2,3, S. Khorasani1,3, F. Dossa3, P. Myrelid4,5

Created: Thursday, 30 January 2020, 10:12 AM
P758: Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn’s disease (SVEAH CD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Eriksson1, S. Rundquist1*, V. Lykiardopoulos2, P. Karlén3, O. Grip4, C. Söderman5, S. Almer6, E. Hertervig7, J. Gunnarsson8, C. Malmgren9, J. Delin10, H. Strid11, M. Sjöberg12, D. Öberg13, D. Bergemalm1, R. Udumyan14, H. Hjortswang2, The SWIBREG SVEAH Study Group, J. Halfvarson1

Created: Thursday, 21 February 2019, 9:14 AM
P758: Elevation in ribosomal and cell cycle gene transcription in macroscopically normal colonic tissue from Icelandic patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Vinayaga-Pavan M.*1, Frampton M.2, Pontikos N.3, Levine A.2, Smith P.2, Jonasson J.4, Björnsson E.4, Segal A.2, Smith A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P758: Prevalence of moderate to vigorous physical activity and sedentary time in adolescents with inflammatory bowel disease: knowing and doing
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Madagh*1, L. Belmesk1, X. Y. Yang1, S. Y. Geng1, F. Chennou1, C. Kanters1, P. Jantchou1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P759 Correlation of quality-of-life components with sexual function scores and disease duration in patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Domislović1, M. Brinar1,2, L. Vujičić2, M. Novosel2, D. Grgić1, Ž. Krznarić1,2

Created: Thursday, 30 January 2020, 10:12 AM